Clinical Trials Logo

Clinical Trial Summary

Background:

- Most of the time, humans make decisions according to their consequences, especially if they will be beneficial, and will avoid or try to avoid doing an action if it has a bad outcome. The way that the brain prepares a movement has been studied in detail, but the way the brain makes decisions before carrying out an action is still poorly understood. Researchers are interested in learning more about the decision-making process and how it affects the brain.

Objectives:

- To record the activity of the brain during decision-making processes.

Eligibility:

- Healthy, right-handed volunteers between 18 and 40 years of age.

Design:

- Potential participants will have a screening visit with a medical history and neurological examination to determine eligibility.

- This study requires seven visits: one magnetic resonance imaging (MRI) visit and 6 magnetoencephalography (MEG) recording visits. The MEG recording visits will include transcranial magnetic stimulation (TMS). All visits will be spaced at least 1 week apart. Total participation will last about 6 weeks.

- Participants will have an MRI scan at the first study visit.

- The MEG procedures will record brain activity during a series of computer tests involving winning or losing money. TMS will be performed during these visits, separate from the test....


Clinical Trial Description

Objective:

The objective is to study cerebral activity associated with reward-related decision making. We plan to analyze and localize electrical activity of the brain related to such processes with magnetoencephalography (MEG). We also want to modulate the activity of these areas using repetitive transcranial magnetic stimulation (rTMS). We would like to analyze the consequences of these procedures on both brain activity and behavioral performance. This protocol will provide new information on cortical regions involved in decision-making and how these areas communicate with one another.

Study population:

50 right-handed adult healthy volunteers.

Design:

A probabilistic reversal task will be performed: subjects will have to choose between pairs of stimuli associated with changing probabilities of rewards and losses. Using MEG, their cerebral activity will be recorded during task performance.

Since we want to modulate the cortical activity of cerebral areas involved in reward-related decision making, the study will be carried out in 8 different visits (screening visit, structural MRI acquisition and 6 recordings visits). In one visit, decision-making will be studied with no previous cortical stimulation. In 3 visits, decision-making will be studied after stimulation of one of 3 regions of interest. In one visit, decision-making will be studied after stimulation of a cortical area that is not thought to be involved in the process. Lastly, decision-making will be analyzed following a sham stimulation to test a possible placebo effect of rTMS.

Outcome measures:

Outcome measures are as follow:

1. Task-related: reaction time and error rate during the task performance.

2. MEG signal: scalp and source coherence between cortical regions, amplitude and latency of event-related potentials and even-related (de)synchronization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01006109
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Terminated
Phase
Start date October 22, 2009
Completion date September 7, 2017

See also
  Status Clinical Trial Phase
Completed NCT04014491 - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome N/A
Recruiting NCT02559752 - Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT01531920 - A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel Phase 1
Completed NCT02652260 - Effects of Switching From ATRIPLAâ„¢ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Phase 2
Recruiting NCT01541800 - Circulating microRNAs as Disease Markers in Pediatric Cancers N/A
Completed NCT02343718 - Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Phase 1
Completed NCT03430427 - Brain Networks and Mobility Function: B-NET
Completed NCT03830762 - Xanamemâ„¢ in Healthy Elderly Subjects Phase 1
Completed NCT01527006 - Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs Phase 2
Completed NCT01517087 - Studying Motor Neuron Tests
Recruiting NCT05627986 - Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Completed NCT01432288 - Touch and Attention MRI Study N/A
Completed NCT00067067 - Investigating Endothelial Precursor Cells (EPCs) N/A
Completed NCT03268239 - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions N/A
Recruiting NCT04846764 - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) N/A